Mark Leschly has served as a member of our board since 2002.
Since July 1999, Mr. Leschly has been a Managing Partner with Rho Capital Partners, an investment and venture capital management company.Previously, Mr. Leschly was an Associate and then a General Partner of HealthCare Ventures, a venture capital management company, from 1994 through 1999.
In addition to serving as a director of Verenium Corporation, NitroMed, Inc., and Tercica, Inc. (a wholly-owned subsidiary of Ipsen). Mr. Leschly is on the board of a number of private companies.
Mr. Leschly received an A.B. from Harvard University and an M.B.A. from the Stanford Graduate School of Business.